Results 201 to 210 of about 993,013 (333)

Endoscopic Innovation Treatment Strategy in Hepatocellular Carcinoma (HCC) Patients Before Immunotherapy: A Case Series Study in Unselected Patients. [PDF]

JGH Open
Syofyan SD, Kovara K, Lesmana NP, Wiradikarta JN, Syofyan JF, Widjaja JB, Inggriani S, Hermawan R, Lesmana CRA.   +8 more
europepmc   +1 more source

Radiological diagnosis of hepatocellular carcinoma

, 2014
Irene Bargellini, Valentina Battaglia, Elena Bozzi, Dario Luca Lauretti, Giulia Lorenzoni, Carlo Bartolozzi Department of Diagnostic and Interventional Radiology, Pisa University Hospital, Pisa, Italy Abstract: Diagnosis of hepatocellular carcinoma (HCC)
Battaglia V, Lauretti DL, Bargellini I, Bartolozzi C, Bozzi E, Lorenzoni G   +5 more
core  

Editorial expression of concern: NMD-1198, a novel tubulin-binding agent reduces HIF-1alpha and STAT3 activity in human hepatocellular carcinoma (HCC) cells, and inhibits growth and vascularization in vivo. [PDF]

BMC Cancer
Moser C, Lang SA, Mori A, Hellerbrand C, Schlitt HJ, Geissler EK, Fogler WE, Stoeltzing O.   +7 more
europepmc   +1 more source

Clinical utility of imaging for evaluation of hepatocellular carcinoma

, 2014
Takamichi Murakami,1 Masakatsu Tsurusaki,1 Tomoko Hyodo,1 Yasuharu Imai2 1Department of Radiology, Kinki University Faculty of Medicine, 2Department of Hepatology and Gastroenterology, Ikeda Municipal Hospital, Osaka, Japan Abstract: The hemodynamics of
Tsurusaki M, Imai Y, Hyodo T, Murakami T
core  

Viability assessment and transplantation of fatty liver grafts using end‐ischemic normothermic machine perfusion

Liver Transplantation, EarlyView., 2022
Abstract End‐ischemic viability testing by normothermic machine perfusion (NMP) represents an effective strategy to recover liver grafts having initially been discarded for liver transplantation (LT). However, its results in the setting of significant (≥30%) macrovesicular steatosis (MaS) have not been specifically assessed.
Damiano Patrono, Riccardo De Carlis, Alessandro Gambella, Francesca Farnesi, Alice Podestà, Andrea Lauterio, Francesco Tandoi, Luciano De Carlis, Renato Romagnoli   +8 more
wiley   +1 more source

Gene Therapy Strategies for Hepatocellular Carcinoma (HCC): Current Landscape and Future Directions. [PDF]

Cancers (Basel)
Ermi AG, Younis RM, Rodriguez K, Sarkar D.   +3 more
europepmc   +1 more source

Editorial: charting the future of hepatocellular carcinoma publications

, 2018
Ahmed Omar Kaseb Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, TX, USAJournal of Hepatocellular Carcinoma (JHC) is a peer-reviewed, comprehensive, multidisciplinary, international journal for ...
Kaseb AO
core  

Toxicity of Ablative Radiation Therapy in the Management of Patients with Child-Pugh B/C Liver Function and Unresectable Hepatocellular Carcinoma (HCC). [PDF]

Cancers (Basel)
Sperduto W, Oyekunle T, Niedzwiecki D, Eyler CE, Czito B, Willett CG, Godfrey D, Salama JK, Palta M, Stephens SJ.   +9 more
europepmc   +1 more source

A Single‑Center Retrospective Cohort Study: Impact of Glycemic Control on First‑Line TKI Plus PD‑1 Inhibitors versus TKI Alone in Intermediate‑to‑advanced Unresectable Hepatocellular Carcinoma(HCC) with Type 2 Diabetes Mellitus (T2DM). [PDF]

J Hepatocell Carcinoma
Liu J, Chen X, Wang R, Peng C, Yu H, Wang W, Ma W, Han J, Liang Z, Yang Y, Cheng J, Lu Y.   +11 more
europepmc   +1 more source

Pharmacogenomics of Sorafenib in Hepatocellular Carcinoma (HCC): A LncRNA-Expression Guided Approach Using UCA1 and MALAT1 for Personalizing Therapy in a 154-Patient Cohort. [PDF]

Pharmaceuticals (Basel)
Nazih M, Waked I, Abdelsattar S, Al-Amodi HS, Kamel HFM, Attia MM, Khoder AI, Hassan SB, Mahmoud Abdel-Latif M.   +8 more
europepmc   +1 more source